Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Action of nifedipine in ischemic heart disease.

Canadian family physician Medecin de famille canadien·2011
Same author

Growth factors, cytokines, and vascular injury.

Trends in cardiovascular medicine·2011
Same author

The treatment of bacillary dysentery in Chinese soldiers with sulfaguanidine and sulfadiazine.

The American journal of the medical sciences·2010
Same author

Cutaneous diphtheria; a report of 140 cases.

The Journal of investigative dermatology·2010
Same author

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.

Neurology·2010
Same author

Process of care is affected by the type of health insurance.

Evidence-based cardiovascular medicine·2005
Same journal

The Role of Telemedicine on Interhospital Transfer Outcomes : A Systematic Review.

Annals of internal medicine·2026
Same journal

Prolonged Short Sleep and Its Effect on Body Weight and Composition : A Pooled Analysis of Randomized Trials.

Annals of internal medicine·2026
Same journal

In AF, LAAC was noninferior to NOAC therapy for a composite efficacy outcome and reduced non-procedure-related bleeding at 3 y.

Annals of internal medicine·2026
Same journal

How AI is affecting medical journals.

Annals of internal medicine·2026
Same journal

In adults with COPD, the BLISS score predicted risk for acute respiratory hospital admission at 2 y.

Annals of internal medicine·2026
Same journal

In AF at risk for stroke and bleeding, LAAC was not noninferior to medical therapy for a composite of thromboembolic and safety events.

Annals of internal medicine·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

Myocardial ischemia: detection and quantitation.

D D Waters, J S Forrester

    Annals of Internal Medicine
    |February 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Detecting myocardial ischemia, a late sign of coronary artery disease, is crucial. Early detection aids in preventing heart attack complications and evaluating treatment effectiveness.

    More Related Videos

    Histological Quantification of Chronic Myocardial Infarct in Rats
    09:45

    Histological Quantification of Chronic Myocardial Infarct in Rats

    Published on: December 11, 2016

    A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
    11:17

    A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

    Published on: November 28, 2025

    Related Experiment Videos

    Last Updated: Jul 6, 2026

    In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
    08:13

    In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

    Published on: February 16, 2016

    Histological Quantification of Chronic Myocardial Infarct in Rats
    09:45

    Histological Quantification of Chronic Myocardial Infarct in Rats

    Published on: December 11, 2016

    A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
    11:17

    A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

    Published on: November 28, 2025

    Area of Science:

    • Cardiology
    • Medical Diagnostics

    Background:

    • Myocardial ischemia at rest is a late manifestation of coronary artery disease.
    • Transient ischemia can be induced by increased myocardial oxygen demand.
    • Physiologic abnormalities from ischemia are detectable through various assessments.

    Purpose of the Study:

    • To highlight the clinical importance of detecting myocardial ischemia.
    • To discuss the challenges and significance of diagnosing ischemia in coronary artery disease.
    • To review methods for assessing ischemia and their role in evaluating therapies.

    Main Methods:

    • Assessment of myocardial perfusion.
    • Evaluation of regional mechanical function.
    • Electrophysiology and metabolism studies.

    Main Results:

    • Current methods for quantifying myocardial ischemia are imprecise.
    • Diagnostic tests vary in sensitivity, specificity, cost, and ease of use.
    • Despite limitations, methods have been used to evaluate therapies for reducing myocardial infarction size.

    Conclusions:

    • Detecting myocardial ischemia is a critical clinical problem due to associated morbidity and mortality.
    • Coronary artery bypass surgery can reverse ischemia before permanent damage.
    • Accurate detection of ischemia is vital for guiding treatment and assessing therapeutic efficacy.